Photo

Photo detail

Stories this photo appears in:

Arrowhead Pharmaceuticals Seeks Approval to Conduct Two Gene Therapy Clinical Trials

Arrowhead Pharmaceuticals Inc., which develops drugs to treat stubborn diseases by silencing the genes that cause them, reported it has filed for federal clearance to conduct to clinical studies of drugs aimed to treat liver disease and hepatitis B.

Tease photo

Pasadena-based Arrowhead Pharmaceuticals Narrows Year-End Loss

Arrowhead Pharmaceuticals Inc., which develops drugs to treat stubborn diseases by silencing the genes that cause them, reported a fiscal 2017 year-end loss of $34 million, down 58 percent from a year ago.

Tease photo